Language selection

Search

Details for: INVEGA SUSTENNA

Company: JANSSEN INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02354217INVEGA SUSTENNAPALIPERIDONE (PALIPERIDONE PALMITATE)50 MG / 0.5 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02354225INVEGA SUSTENNAPALIPERIDONE (PALIPERIDONE PALMITATE)75 MG / 0.75 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02354233INVEGA SUSTENNAPALIPERIDONE (PALIPERIDONE PALMITATE)100 MG / 1 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02354241INVEGA SUSTENNAPALIPERIDONE (PALIPERIDONE PALMITATE)150 MG / 1.5 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: